FY 26 DOD Appropriations FY 26 HHS Appropriations Biodefense Funding
2025 · 1st Quarter (Jan 1 - Mar 31)
PARATEK PHARMACEUTICALS
Filed by PARATEK PHARMACEUTICALS.
Open official filingSource-reported fields
Filing overview
- Type
- 1st Quarter - Report
- Posted
- Mar 28, 2025
- Income
- Not reported
- Expenses
- $10,000.00
- Registrant
- PARATEK PHARMACEUTICALS
- Client
- PARATEK PHARMACEUTICALS
- Filing UUID
- 0571fd7a-b582-4359-baa7-bd2e29d76dc4
- Termination date
- Not reported
Expense method: A
Literal source text
Lobbying issues and bill citations
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.